MedTrace Logo

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

NCT06671808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 222128

Last updated 2024-11-04

No results posted yet for this study

Summary

This study aims to investigate the relationship between HIV infection and multi-drug resistant tuberculosis (MDR-TB) among affected individuals in Zahedan, Iran. It will involve a detailed analysis of patient demographics, clinical characteristics, and treatment outcomes to enhance understanding of this co-infection. The findings may inform better treatment strategies and healthcare policies for managing these diseases in similar populations.

Conditions

  • HIV Infection
  • MDR-TB

Interventions

OTHER

Examination of HIV Infection in Patients with Multi-Drug Resistant Tuberculosis (MDR-TB)

This meta-analysis examines the impact of HIV infection on the prevalence and outcomes of multi-drug resistant tuberculosis (MDR-TB) among affected populations. The analysis synthesizes data from multiple studies conducted across various countries, focusing on the correlation between HIV co-infection and MDR-TB rates, treatment outcomes, and demographic factors. The findings aim to enhance understanding of the complex interactions between HIV and MDR-TB, ultimately informing clinical practices and public health strategies.

Sponsors & Collaborators

  • Zahedan University of Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2024-08-22
Completion
2024-09-03

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06671808 on ClinicalTrials.gov